Statistics : a bayesian perspective.

Por Berry, Donald A.
Publicado em c199

Bayesian biostatistics/

Por Berry, Donald A.
Publicado em c199

Using biomarkers prospectively in adaptive clinical trials

Por Berry, Donald A
Publicado em 2011

Bayesian approaches for comparative effectiveness research

Por Berry, Donald A
Publicado no Clin Trials (2011)

The Brave New World of clinical cancer research: Adaptive biomarker‐driven trials integrating clinical practice with clinical research

Por Berry, Donald A.
Publicado no Mol Oncol (2015)

Right-sizing Adjuvant and Neoadjuvant Clinical Trials in Breast Cancer

Por Berry, Donald A.
Publicado no Clin Cancer Res (2015)

From drug discovery to biomarker-driven clinical trials in lymphoma

Por Younes, Anas, Berry, Donald A.
Publicado no Nat Rev Clin Oncol (2012)

Statistics : theory and methods /

Por Berry, Donald A., Lindgren, Bernard William.
Publicado em c199

Detecting an Overall Survival Benefit that Is Derived From Progression-Free Survival

Por Broglio, Kristine R., Berry, Donald A.
Publicado em 2009

A new Bayesian approach incorporating covariate information for heterogeneity and its comparison with HLOD

Por Biswas, Swati, Lin, Shili, Berry, Donald A
Publicado em 2005

Reports from 2010 Clinical and Translational Cancer Research Think Tank Meeting: Design Strategies for Personalized Therapy Trials

Por Berry, Donald A., Herbst, Roy S., Rubin, Eric H.
Publicado no Clin Cancer Res (2012)

Predicting clinical trial results based on announcements of interim analyses

Por Broglio, Kristine R, Stivers, David N, Berry, Donald A
Publicado em 2014

Bayesian Clinical Trials at the University of Texas M. D. Anderson Cancer Center

Por Biswas, Swati, Liu, Diane D., Lee, J. Jack, Berry, Donald A.
Publicado em 2009

Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials

Por Berry, Scott M, Broglio, Kristine R, Groshen, Susan, Berry, Donald A
Publicado no Clin Trials (2013)

Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trials

Por Trippa, Lorenzo, Wen, Patrick Y., Parmigiani, Giovanni, Berry, Donald A., Alexander, Brian M.
Publicado no Neuro Oncol (2015)

Using Molecular Sizes of Simple Sequence Repeats vs. Discrete Binned Data in Assessing Probability of Ancestry: Application to Maize Hybrids

Por Berry, Donald A., Wright, Deanne, Xie, Chongqing, Seltzer, Jon D., Smith, J. Stephen C.
Publicado em 2005

Using short-term response information to facilitate adaptive randomization for survival clinical trials

Por Huang, Xuelin, Ning, Jing, Li, Yisheng, Estey, Elihu, Issa, Jean-Pierre, Berry, Donald A.
Publicado em 2009

Body Mass Index and Breast Cancer Risk According to Postmenopausal Estrogen-Progestin Use and Hormone Receptor Status

Por Munsell, Mark F., Sprague, Brian L., Berry, Donald A., Chisholm, Gary, Trentham-Dietz, Amy
Publicado em 2014

Assessing probability of ancestry using simple sequence repeat profiles: applications to maize hybrids and inbreds.

Por Berry, Donald A, Seltzer, Jon D, Xie, Chongqing, Wright, Deanne L, Smith, J Stephen C
Publicado em 2002

Prognostic Role of Detection Method and its Relationship with Tumor Biomarkers in Breast Cancer: M. D. Anderson Cancer Center Experience

Por Dong, Wenli, Berry, Donald A., Bevers, Therese B., Kau, Shu-Wan, Hsu, Limin, Theriault, Richard L., Shen, Yu
Publicado em 2008